MYMX Financials: Mymetics Corp AI Analysis

Home

Stock

MYMX

Financials

MYMX Financial

Mymetics Corp

At close: Mar 27, 16:00:00 GMT-4

Post-market: Mar 27, 19:22:37 GMT-4

Overview Forecast Earnings Dividends Financials

Key Stats

Prev.Close

$0.0003

Open

$0.0003

Day's Range

$0.0003 - $0.0003

52 week range

$0.0003 - $0.001

Volume

100

Avg.Volume

Dividend yield

EPS (TTM)

-70.19

Market Cap

$44.99999999999999

What is MYMX?

Mymetics Corp. is a vaccine company, which focuses on the research and development of next generation vaccines for infectious and life disabling diseases. The company is headquartered in Epalinges, Vaud and currently employs 8 full-time employees. The firm is focused on developing vaccines for infectious diseases. The firm has over five vaccine candidates in its pipeline: human immunodeficiency virus type 1 (HIV-1)/acquired immune deficiency syndrome (AIDS), intra nasal Influenza, Malaria, Herpes Simplex Virus (HSV) and the Respiratory Syncitial Virus (RSV) vaccine. Its technology utilizes virosomes, lipid-based carriers containing functional fusion viral proteins and natural membrane proteins, in combination with rationally designed antigens. Its prophylactic HIV-1 vaccine candidate is constituted of virosomes linked to conserved antigens derived from the HIV-1 glycoprotein 41 (gp41) proteins from the clade B. The RSV vaccine consists of the reconstituted membrane of RSV containing the native viral proteins. The HSV vaccine candidate consists of the reconstituted membrane of HSV-1 or HSV-2. The intranasal influenza vaccine includes the reconstituted membrane of influenza virus.



Features

AI Copilot for Stock & Crypto

Resources

Market

Income

Balance sheet

Cash flow

Annual

Quarterly

MYMX Income

Financials in millions USD. Fiscal year is February - January.

Breakdown	TTM	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018
Revenue	0	1	0	0	0	0
Revenue Growth (YoY)	--	--	--	--	--	-100%
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	1	1	1	1	1	1
Research & Development	1	1	0	1	0	1
Operating Expenses	2	2	2	2	2	2
Other Non Operating Income (Expenses)	0	0	0	0	--	--
Pretax Income	-11	-4	-4	-4	-4	-4
Income Tax Expense	--	0	0	0	0	0
Net Income	-11	-4	-4	-4	-4	-4
Net Income Growth	120%	0%	0%	0%	0%	0%
Shares Outstanding (Diluted)	0.15	0.15	0.15	0.15	303.75	303.75
Shares Change (YoY)	-100%	0%	0%	-100%	0%	0%
EPS (Diluted)	-76.15	-31.63	-31.14	-27.37	-0.01	-0.01
EPS Growth	450,492%	2%	14%	198,285%	1%	1%
Free Cash Flow	-1	-1	-1	-1	-1	-2
Free Cash Flow Per Share	--	--	--	--	--	--
Gross Margin	--	--	--	--	--	--
Operating Margin	0%	-100%	0%	0%	0%	0%
Profit Margin	0%	-400%	0%	0%	0%	0%
Free Cash Flow Margin	0%	-100%	0%	0%	0%	0%
EBITDA	-2	-1	-1	-1	-1	-1
EBITDA Margin	0%	-100%	0%	0%	0%	0%
D&A For EBITDA	0	0	0	0	0	0
EBIT	-2	-1	-1	-1	-1	-1
EBIT Margin	0%	-100%	0%	0%	0%	0%
Effective Tax Rate	--	0%	0%	0%	0%	0%

Follow-Up Questions

What are Mymetics Corp's key financial statements?



According to the latest financial statement (Form-10K), Mymetics Corp has a total asset of $7, Net loss of $-4

What are the key financial ratios for MYMX?



Mymetics Corp's Current ratio is 0.09, has a Net margin is -400, sales per share of $6.58.

How is Mymetics Corp's revenue broken down by segment or geography?



Mymetics Corp largest revenue segment is Aiful Corporation, at a revenue of 109,884,000,000 in the most earnings release.For geography, Japan is the primary market for Mymetics Corp, at a revenue of 189,054,000,000.

Is Mymetics Corp profitable?



no, according to the latest financial statements, Mymetics Corp has a net loss of $-4

Does Mymetics Corp have any liabilities?



yes, Mymetics Corp has liability of 72

How many outstanding shares for Mymetics Corp?



Mymetics Corp has a total outstanding shares of 0.15

Mymetics Corp (MYMX) Financial

MYMX Stock Price Chart